|
Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adenocarcinoma: An AGEO European Cohort. |
| |
|
Employment - Pierre Fabre (I) |
| |
|
No Relationships to Disclose |
| |
|
Honoraria - Roche Pharma AG; Taiho Pharmaceutical |
Consulting or Advisory Role - SERVIER (Inst) |
Travel, Accommodations, Expenses - Amgen; Lilly; Merck KGaA; SERVIER |
| |
|
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; MSD |
Speakers' Bureau - Amgen; AstraZeneca; Bristol-Myers Squibb; MSD |
| |
|
Travel, Accommodations, Expenses - Ipsen; Merck |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo; Incyte; Lilly; Merck Serono; Mirati Therapeutics; MSD; SERVIER |
Speakers' Bureau - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Merck Serono; Mirati Therapeutics; MSD Oncology; Pierre Fabre; Roche; Servier |
Research Funding - Amgen; AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck Serono; Roche (Inst) |
| |
|
Consulting or Advisory Role - Amgen; Bayer; BeiGene; Biocartis; Bristol-Myers Squibb; Lilly O.; MSD; Pfizer; Pierre Fabre; Roche; Sanofi; SeqOne Genomics; SERVIER; Takeda |
Speakers' Bureau - Amgen; Bayer; BeiGene; Biocartis; Bristol-Myers Squibb; Lilly O.; MSD; Pfizer; Pierre Fabre; Roche; Sanofi; SeqOne Genomics; SERVIER; Takeda |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Honoraria - Advanced Accelerator Applications; Amgen; Ipsen; Merck KGaA; Novartis; Sanofi; SERVIER |
|
Travel, Accommodations, Expenses - Amgen; Ipsen; Novartis; Pfizer; Sanofi |
| |
|
Consulting or Advisory Role - Roche |
Speakers' Bureau - Bayer; TERUMO |
Travel, Accommodations, Expenses - Roche |
| |
|
Consulting or Advisory Role - Merck Serono; Pierre Fabre; SERVIER |
Research Funding - Amgen (Inst) |
Travel, Accommodations, Expenses - Merck Serono; Pierre Fabre; Sanofi |
| |
|
No Relationships to Disclose |
| |
|
Honoraria - Accademia Nazionale Di Medicina (ACCMED); Incyte; medpoint SRL; Sandoz; SERVIER |
Consulting or Advisory Role - Basilea Pharmaceutical; EMD Serono; Incyte; MSD/AstraZeneca; SERVIER; Taiho Pharmaceutical |
Travel, Accommodations, Expenses - AstraZeneca |
| |
|
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo Pharmaceutical; Lilly O.; Merck Serono; MSD; Pierre Fabre (I); Roche; SERVIER |
Speakers' Bureau - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo Pharmaceutical; Lilly O.; Merck Serono; MSD; Pierre Fabre; Roche; SERVIER; SERVIER |
| |
|
Honoraria - Amgen; Merck Serono; SERVIER |
Consulting or Advisory Role - SERVIER |
Speakers' Bureau - Amgen; Merck Serono; SERVIER |
Travel, Accommodations, Expenses - Amgen; SERVIER |
| |
|
Honoraria - Bayer; GlaxoSmithKline; Ipsen; Merck Serono; Roche; SERVIER; Sirtex Medical; Taiho Pharmaceutical |
Consulting or Advisory Role - BMS; Celgene; MSD; Rafael Pharmaceuticals; RedHill Biopharma; Roche; Shire |
Research Funding - Boehringer Ingelheim (Inst); Roche (Inst) |
Travel, Accommodations, Expenses - Array BioPharma; Bayer; Celgene; Halozyme; RedHill Biopharma; Roche; SERVIER; Taiho Pharmaceutical |
| |
|
Consulting or Advisory Role - Amgen; Sanofi |
Research Funding - Institut SERVIER |
| |
|
Consulting or Advisory Role - Amgen; AstraZeneca; BMS; Merck KGaA; MSD; Novartis; Pierre Fabre; Roche; SERVIER |
Speakers' Bureau - Amgen; Merck; MSD; Pierre Fabre; SERVIER |